Clarus Lifesciences II, L.P. Insider Trading Transactions
Get free email notifications about insider trading for Clarus Lifesciences II, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Clarus Lifesciences II, L.P.. Clarus Lifesciences II, L.P. is 10% Owner in ACHILLION PHARMACEUTICALS INC ($ACHN) and 10% Owner in AERIE PHARMACEUTICALS INC ($AERI) and 10% Owner in TETRALOGIC PHARMACEUTICALS CORP ($TLOG) and 10% Owner in Blackstone Group L.P. ($BX) and 10% Owner in NanoString Technologies Inc ($NSTG) and 10% Owner in Ophthotech Corp. ($OPHT) and 10% Owner in Restoration Robotics Inc ($HAIR) and 10% Owner in CATABASIS PHARMACEUTICALS INC ($CATB).
Latest Insider Trading Transactions of Clarus Lifesciences II, L.P.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACHN, AERI, BX, CATB, OPHT, NSTG, TLOG, VERO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 22 2019 | NSTG | NanoString Technol ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 21.62 | 2,000,000 | 43,240,000 | 2,036,025 | 4 M to 2 M (-49.55 %) |
Mar 22 2019 | BX | Blackstone Group L ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 21.62 | 2,000,000 | 43,240,000 | 2,036,025 | 4 M to 2 M (-49.55 %) |
Sep 19 2018 | NSTG | NanoString Technol ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | X | 8.45 | 162,408 | 1,372,023 | 0 | |
Sep 19 2018 | NSTG | NanoString Technol ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | X | 8.45 | 162,408 | 1,372,023 | 0 | |
Sep 19 2018 | NSTG | NanoString Technol ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 15.99 | 85,823 | 1,372,310 | 4,036,025 | 4.1 M to 4 M (-2.08 %) |
Sep 19 2018 | NSTG | NanoString Technol ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 15.99 | 85,823 | 1,372,310 | 4,036,025 | 4.1 M to 4 M (-2.08 %) |
Sep 19 2018 | NSTG | NanoString Technol ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | X | 8.45 | 162,408 | 1,372,023 | 4,121,848 | 4 M to 4.1 M (+4.10 %) |
Sep 19 2018 | NSTG | NanoString Technol ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | X | 8.45 | 162,408 | 1,372,023 | 4,121,848 | 4 M to 4.1 M (+4.10 %) |
Oct 17 2017 | HAIR | Restoration Roboti ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,389,105 | 0 | 0 | |
Oct 17 2017 | HAIR | Restoration Roboti ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | C | 7.00 | 180,881 | 1,266,167 | 3,569,986 | 3.4 M to 3.6 M (+5.34 %) |
Oct 17 2017 | HAIR | Restoration Roboti ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | C | 0.00 | 3,389,105 | 0 | 3,389,105 | 0 to 3.4 M |
Jan 04 2017 | NSTG | NanoString Technol ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | A | 22.30 | 8,611 | 192,025 | 8,611 | |
Feb 10 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.16 | 230,507 | 36,881 | 2,214,523 | 2.4 M to 2.2 M (-9.43 %) |
Feb 10 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.19 | 103,123 | 19,593 | 2,445,030 | 2.5 M to 2.4 M (-4.05 %) |
Feb 05 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.20 | 832,881 | 166,576 | 2,548,153 | 3.4 M to 2.5 M (-24.63 %) |
Feb 05 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.14 | 500,026 | 70,004 | 3,381,034 | 3.9 M to 3.4 M (-12.88 %) |
Feb 05 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.15 | 82,583 | 12,387 | 3,881,060 | 4 M to 3.9 M (-2.08 %) |
Feb 02 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.17 | 176,306 | 29,972 | 3,963,643 | 4.1 M to 4 M (-4.26 %) |
Feb 02 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.20 | 140,000 | 28,000 | 4,139,949 | 4.3 M to 4.1 M (-3.27 %) |
Feb 02 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.26 | 52,826 | 13,735 | 4,279,949 | 4.3 M to 4.3 M (-1.22 %) |
Jan 28 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.26 | 32,521 | 8,455 | 4,332,775 | 4.4 M to 4.3 M (-0.74 %) |
Jan 28 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.27 | 209,984 | 56,696 | 4,365,296 | 4.6 M to 4.4 M (-4.59 %) |
Jan 28 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.30 | 69,425 | 20,828 | 4,575,280 | 4.6 M to 4.6 M (-1.49 %) |
Jan 05 2016 | NSTG | NanoString Technol ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | A | 14.71 | 7,828 | 115,150 | 7,828 | |
Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 9,728,971 | 0 | 0 | |
Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 20,800,000 | 0 | 0 | |
Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | P | 12.00 | 376,695 | 4,520,340 | 2,752,488 | 2.4 M to 2.8 M (+15.86 %) |
Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | C | 0.00 | 757,117 | 0 | 2,375,793 | 1.6 M to 2.4 M (+46.77 %) |
Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | C | 0.00 | 1,618,676 | 0 | 1,618,676 | 0 to 1.6 M |
May 28 2015 | OPHT | Ophthotech Corp. | Clarus Lifesciences II, L.P. | 10% Owner | Sell | J | 0.00 | 1,554,744 | 0 | 0 | 1.6 M to 0 (-100.00 %) |
Jan 30 2015 | AERI | AERIE PHARMACEUTIC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | J | 0.00 | 3,139,447 | 0 | 0 | 3.1 M to 0 (-100.00 %) |
Jan 12 2015 | AERI | AERIE PHARMACEUTIC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 31.11 | 175,000 | 5,444,250 | 3,324,259 | 3.5 M to 3.3 M (-5.00 %) |
Jan 06 2015 | AERI | AERIE PHARMACEUTIC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 31.11 | 10,200 | 317,322 | 3,499,259 | 3.5 M to 3.5 M (-0.29 %) |
Jan 06 2015 | AERI | AERIE PHARMACEUTIC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 30.67 | 13,420 | 411,591 | 3,509,459 | 3.5 M to 3.5 M (-0.38 %) |
Dec 30 2014 | AERI | AERIE PHARMACEUTIC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 30.03 | 6,214 | 186,606 | 3,522,879 | 3.5 M to 3.5 M (-0.18 %) |
Dec 30 2014 | AERI | AERIE PHARMACEUTIC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 30.05 | 74,510 | 2,239,026 | 3,529,093 | 3.6 M to 3.5 M (-2.07 %) |
Dec 24 2014 | AERI | AERIE PHARMACEUTIC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 30.00 | 263 | 7,890 | 3,603,603 | 3.6 M to 3.6 M (-0.01 %) |
Dec 24 2014 | AERI | AERIE PHARMACEUTIC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 30.36 | 49,441 | 1,501,029 | 3,603,866 | 3.7 M to 3.6 M (-1.35 %) |
Jun 11 2014 | OPHT | Ophthotech Corp. | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 44.32 | 500 | 22,160 | 4,500 | 5 K to 4.5 K (-10.00 %) |
Jun 11 2014 | OPHT | Ophthotech Corp. | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 44.53 | 29,217 | 1,301,074 | 2,843,564 | 2.9 M to 2.8 M (-1.02 %) |
Jun 11 2014 | OPHT | Ophthotech Corp. | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 46.80 | 200 | 9,360 | 2,872,781 | 2.9 M to 2.9 M (-0.01 %) |
Jun 11 2014 | OPHT | Ophthotech Corp. | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 45.90 | 36,880 | 1,692,630 | 2,872,981 | 2.9 M to 2.9 M (-1.27 %) |
Jun 11 2014 | OPHT | Ophthotech Corp. | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 44.66 | 79,824 | 3,564,988 | 2,909,861 | 3 M to 2.9 M (-2.67 %) |
Jun 11 2014 | OPHT | Ophthotech Corp. | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 46.78 | 39,362 | 1,841,500 | 2,989,685 | 3 M to 3 M (-1.30 %) |
Jun 11 2014 | OPHT | Ophthotech Corp. | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 46.02 | 25,697 | 1,182,463 | 3,029,047 | 3.1 M to 3 M (-0.84 %) |
Jun 16 2014 | AERI | AERIE PHARMACEUTIC ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | A | 17.55 | 13,500 | 236,925 | 13,500 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | X | 6.40 | 23,282 | 149,056 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | C | 7.00 | 853,416 | 5,973,912 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,342,944 | 0 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | X | 6.40 | 23,282 | 149,056 | 4,644,705 | 4.6 M to 4.6 M (+0.50 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | C | 7.00 | 853,416 | 5,973,912 | 4,621,423 | 3.8 M to 4.6 M (+22.65 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | C | 0.00 | 2,342,944 | 0 | 3,768,007 | 1.4 M to 3.8 M (+164.41 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | P | 7.00 | 1,425,063 | 9,975,441 | 1,425,063 | 0 to 1.4 M |
Oct 02 2013 | OPHT | Ophthotech Corp. | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 186,027 | 0 | 0 | |
Oct 02 2013 | OPHT | Ophthotech Corp. | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,542,373 | 0 | 0 | |
Oct 02 2013 | OPHT | Ophthotech Corp. | Clarus Lifesciences II, L.P. | 10% Owner | Buy | C | 0.00 | 186,027 | 0 | 2,728,390 | 2.5 M to 2.7 M (+7.32 %) |
Oct 02 2013 | OPHT | Ophthotech Corp. | Clarus Lifesciences II, L.P. | 10% Owner | Buy | C | 0.00 | 2,542,373 | 0 | 2,542,373 | 0 to 2.5 M |
Oct 28 2013 | AERI | AERIE PHARMACEUTIC ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 420,222 | 0 | 0 | |
Oct 28 2013 | AERI | AERIE PHARMACEUTIC ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | C | 0.05 | 184,812 | 9,241 | 0 | |
Oct 28 2013 | AERI | AERIE PHARMACEUTIC ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,727,272 | 0 | 0 | |
Oct 28 2013 | AERI | AERIE PHARMACEUTIC ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | P | 10.00 | 321,000 | 3,210,000 | 3,653,306 | 3.3 M to 3.7 M (+9.63 %) |
Oct 28 2013 | AERI | AERIE PHARMACEUTIC ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | C | 0.05 | 184,812 | 9,241 | 3,332,306 | 3.1 M to 3.3 M (+5.87 %) |
Oct 28 2013 | AERI | AERIE PHARMACEUTIC ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | C | 0.00 | 420,222 | 0 | 3,147,494 | 2.7 M to 3.1 M (+15.41 %) |
Oct 28 2013 | AERI | AERIE PHARMACEUTIC ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | C | 0.00 | 2,727,272 | 0 | 2,727,272 | 0 to 2.7 M |
Jun 06 2012 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | J | 0.00 | 10,942,468 | 0 | 3 | 10.9 M to 3 (-100.00 %) |
Jun 04 2012 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | X | 3.53 | 1,290,922 | 4,556,955 | 0 | |
Jun 04 2012 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | X | 3.11 | 1,706,426 | 5,311,251 | 0 | |
Jun 04 2012 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 7.49 | 708,810 | 5,311,255 | 10,942,471 | 11.7 M to 10.9 M (-6.08 %) |
Jun 04 2012 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 7.49 | 608,146 | 4,556,960 | 11,651,281 | 12.3 M to 11.7 M (-4.96 %) |
Jun 04 2012 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | X | 3.11 | 1,706,426 | 5,311,251 | 12,259,427 | 10.6 M to 12.3 M (+16.17 %) |
Jun 04 2012 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | X | 3.53 | 1,290,922 | 4,556,955 | 10,553,001 | 9.3 M to 10.6 M (+13.94 %) |
Aug 20 2010 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | P | 3.11 | 1,706,426 | 5,311,251 | 1,706,426 | |
Aug 20 2010 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | P | 2.49 | 4,875,502 | 12,140,000 | 9,262,079 | 4.4 M to 9.3 M (+111.15 %) |
Jan 13 2010 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 3.77 | 233,990 | 881,370 | 4,386,577 | 4.6 M to 4.4 M (-5.06 %) |
Jan 08 2010 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 3.50 | 3,600 | 12,600 | 4,620,567 | 4.6 M to 4.6 M (-0.08 %) |
Jan 08 2010 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 3.50 | 49,400 | 173,033 | 4,624,167 | 4.7 M to 4.6 M (-1.06 %) |
Dec 29 2009 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 3.53 | 3,600 | 12,695 | 4,673,567 | 4.7 M to 4.7 M (-0.08 %) |
Dec 23 2009 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 3.70 | 264,900 | 981,428 | 4,677,167 | 4.9 M to 4.7 M (-5.36 %) |
Dec 23 2009 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 3.54 | 19,100 | 67,664 | 4,942,067 | 5 M to 4.9 M (-0.38 %) |
Dec 18 2009 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 3.50 | 9,900 | 34,650 | 4,961,167 | 5 M to 5 M (-0.20 %) |
Dec 18 2009 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 3.50 | 129,476 | 453,166 | 4,971,067 | 5.1 M to 5 M (-2.54 %) |
Dec 18 2009 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 3.58 | 67,800 | 242,507 | 5,100,543 | 5.2 M to 5.1 M (-1.31 %) |
Sep 09 2008 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | P | 2.37 | 1,600 | 3,791 | 5,307,420 | 5.3 M to 5.3 M (+0.03 %) |
Sep 09 2008 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | P | 2.19 | 3,054 | 6,693 | 5,305,820 | 5.3 M to 5.3 M (+0.06 %) |
Page: 1